GSE115542 digoxin 5 v 0 human dn (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE115542_digoxin_5_v_0_human_dn.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE115542_digoxin_5_v_0_human_dn.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE115542_digoxin_5_v_0_human_dn.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE115542_digoxin_5_v_0_human_dn.

Results found

Linked to

 

Label

Description

 

Gene

general transcription factor IIi pseudogene 4

Gene

MT-ATP6 pseudogene 1

Gene

zinc finger protein 300 pseudogene 1

Gene

uncharacterized LOC101927855

Gene

long intergenic non-protein coding RNA 2289

Gene

long intergenic non-protein coding RNA 1354

Gene

uncharacterized LOC102723878

Gene

translation initiation factor IF-2-like

Gene

vomeronasal 1 receptor 60 pseudogene

Gene

GUSB pseudogene 12

  • Gene

    general transcription factor IIi pseudogene 4


  • Gene

    MT-ATP6 pseudogene 1


  • Gene

    zinc finger protein 300 pseudogene 1


  • Gene

    uncharacterized LOC101927855


  • Gene

    long intergenic non-protein coding RNA 2289


  • Gene

    long intergenic non-protein coding RNA 1354


  • Gene

    uncharacterized LOC102723878


  • Gene

    translation initiation factor IF-2-like


  • Gene

    vomeronasal 1 receptor 60 pseudogene


  • Gene

    GUSB pseudogene 12

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.